Full Schedule

Lead Speaker: Petra Denig, PharmD, PhD, FISPE – University Medical Center Groningen

Lead Speaker: Lotte Rasmussen, MScPharm, PhD – Syddansk Universitet

Speaker: Mina Tadrous, PharmD, PhD, MS, FISPE – University of Toronto

Speaker: Lisa G. Pont, PhD – Discipline of Pharmacy, University of Technology Sydney, Sydney, NSW, Australia

Speaker: Björn Wettermark, MscPharm, PhD (he/him/his) – Uppsala university

Moderator: Juan M. Hincapie-Castillo, PharmD, MS, PhD (he/him/his) – University of North Carolina at Chapel Hill

Moderator: Caitlin Knox, PhD MPH (she/her/hers) – Regeneron Pharmaceuticals, Inc.

Speaker: Vincent Lo Re, III, MD, MSCE (he/him/his) – Perelman School of Medicine at the University of Pennsylvania

Speaker: Mary Beth E. Ritchey, PhD, FISPE – Food and Drug Administration

Speaker: Robert W. Platt, PhD (he/him/his) – Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada

Lead Speaker: Amalia M. Issa, PhD, MPH, FISPE

Lead Speaker: Gillian Bartlett-Esquilant, PhD, FISPE – University of Missouri School of Medicine

Speaker: Stephen E. Kimmel, MD, MSCE, FISPE – University of Florida

Speaker: Anke-Hilse Maitland-van der Zee, PharmD, PhD (she/her/hers) – Amsterdam UMC

Speaker: Bruce C. Carleton, PharmD, FCP, FISPE – University of British Columbia

Lead Speaker: Natasha Pratt, PhD (she/her/hers) – U.S. Food and Drug Administration

Speaker: Christian Hampp, PhD, FISPE (he/him/his) – Regeneron Pharmaceuticals, Inc., Tarrytown, NY

Speaker: Jessica Jalbert, PhD (she/her/hers) – Regeneron

Speaker: Soko Setoguchi, MD, DrPH, FISPE – Department of Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ

Speaker: Ximena Camacho, MMath (she/her/hers) – UNSW Sydney

Speaker: Hui-Lee Wong, PhD (she/her/hers) – US Food and Drug Administration

Speaker: Silvia Perez-Vilar, PhD, PharmD – US Food and Drug Administration

Speaker: Olivier Humblet

Lead Speaker: Tobias Gerhard, PhD, FISPE (he/him/his) – Center for Pharmacoepidemiology and Treatment Science, Rutgers University

Speaker: Almut G. Winterstein, PhD, FISPE – University of Florida, Pharmaceutical Outcomes & Policy, Center for Drug Evaluation & Safety

Speaker: Tania Schink, Dr, MPH (she/her/hers) – Leibniz Institute for Prevention Research and Epidemiology - BIPS

Lead Speaker: Danica Marinac-Dabic, MD, PhD, MMSc, FISPE (she/her/hers) – FDA/CDRH/ Office of Clinical Evidence and Analysis

Speaker: Katherine Donegan, PhD – Medicines and Healthcare products Regulatory Agency

Lead Speaker: Kevin Haynes, PharmD, MSCE (he/him/his) – Janssen Pharmaceuticals

Speaker: Rosa Gini, PhD (she/her/hers) – ARS Toscana, Florence, Italy

Speaker: Matthew Reynolds, PhD, FISPE – Flatiron Health

Speaker: Daniel C. Beachler, PhD, MHS (he/him/his) – Carelon Research

Speaker: Sudha R. Raman, PhD (she/her/hers) – Department of Population Health Sciences, Duke University School of Medicine, Durham, NC

Lead Speaker: Andrew Freedman, PhD, FISPE – DHHS/NIH/NICHD

Lead Speaker: Bruce C. Carleton, PharmD, FCP, FISPE – University of British Columbia

Speaker: Donna R. Rivera, PharmD, MSc, FISPE – Oncology Center of Excellence, US Food and Drug Administration

Speaker: Wei Zhou, MD, PhD, FISPE (he/him/his) – Eli Lilly and Company

Speaker: Geoffrey Liu, MSc, MD (he/him/his) – Princess Margaret Cancer Centre, University Health Network, Toronto, Canada

Lead Speaker: Michele Jonsson Funk, PhD, FISPE (she/her/hers) – UNC Chapel Hill Gillings School of Global Public Health

Speaker: Jennifer L. Lund, PhD, FISPE (she/her/hers) – Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill

Speaker: Sudha R. Raman, PhD (she/her/hers) – Department of Population Health Sciences, Duke University School of Medicine, Durham, NC

Speaker: Mugdha Gokhale, PhD – Pfizer

Speaker: Til Stürmer, MD, PhD (he/him/his) – Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill

Speaker: Jessica C. Young, PhD (she/her/hers) – Karolinska Institutet

Lead Speaker: Jennifer Christian, PharmD,PhD, FISPE (she/her/hers) – TargetRWE

Lead Speaker: Priscilla Velentgas, MS, PhD (she/her/hers) – Merck

Speaker: Cynthia J. Girman, DrPH FISPE – CERobs Consulting, LLC

Speaker: Anne Trontell, MPH, MD (she/her/hers) – Patient Centered Outcomes Research Institute

Speaker: Jay Park, PhD (he/him/his) – Core Clinical Sciences

Speaker: Kathleen E. Hurwitz, ScD (she/her/hers) – Target RWE

Lead Speaker: Jenny Sun, PhD – Pfizer, Inc.

Speaker: Tamar Lasky, PhD, FISPE (she/her/hers) – US FDA

Speaker: Daniel B. Horton, MD, MSCE, FISPE (he/him/his) – Department of Pediatrics, Rutgers Robert Wood Johnson Medical School; Rutgers University, New Brunswick, NJ, USA

Speaker: Mehmet Burcu, PhD, MS (he/him/his) – Merck & Co., Inc., Rahway, NJ, United States

Speaker: Ann W. McMahon, MD, MS, FISPE – Office of Pediatric Therapeutics

Lead Speaker: John D. Seeger, PharmD, DrPH, FISPE – Optum Epidemiology

Speaker: Jeremy A. Rassen, ScD, FISPE – Aetion

Lead Speaker: Emily W. Bratton, MSPH, PhD (she/her/hers) – IQVIA

Speaker: Laura Hester, PhD – Janssen R&D, LLC

Speaker: Xabier Garcia de Albeniz Martinez, MD, ScM, PhD – RTI Health Solutions

Speaker: Jie Li, PhD – US Food and Drug Administration

Lead Speaker: Katja Taxis, MSc, PhD, FISPE – University of Groningen

Speaker: Lisa G. Pont, PhD – Discipline of Pharmacy, University of Technology Sydney, Sydney, NSW, Australia

Speaker: Jennifer E. Isenor, BSc(Pharm), PharmD, RPh (she/her/hers) – College of Pharmacy, Dalhousie University

Lead Speaker: Alicia W. Gilsenan, PhD, RPh, FISPE – RTI Health Solutions

Speaker: Tarek A. Hammad, MD, PhD, MSc, MS, FISPE – Takeda

Speaker: Juhaeri Juhaeri, PhD – Epidemiology & Benefit - Risk Evaluation, Sanofi

Speaker: Bennett S. Levitan, MD-PhD – Janssen Pharmaceuticals

Speaker: Carol Mansfield, PhD – RTI Health Solutions